SouthState’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$311 Buy
+325
New +$360 ﹤0.01% 1332

Other funds holding LCTX

SouthState's LCTX Position: Q3 2026 in Review

SouthState opened a new position in Lineage Cell Therapeutics (LCTX) in Q3 2026: 325 shares worth $311. The stake represents ﹤0.01% of the portfolio and ranks #1332 among its holdings.

109 funds tracked by Wall St. Rank hold LCTX as of Q3 2026.

  • SouthState held 325 shares of Lineage Cell Therapeutics worth $311 as of Q3 2026.
  • Lineage Cell Therapeutics was a new SouthState position in Q3 2026.
  • Lineage Cell Therapeutics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1332 holding.
  • 109 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.